Will IPOs Come Back? Investors Watching Anthera; Big Pharma Should Too
This article was originally published in The Pink Sheet Daily
Executive Summary
Anthera's planned offering will be the first real IPO in 18 months and a good indicator of whether there are signs of life in the biotech IPO market.